Healthcare / Health Information ServicesSwiss
$6.24
+0.04 (+0.65%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 19%
FCF escenarios
weak_data · normalized FCF $16.3M · quality 41.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$229M
P/E
14.9x
↓EV/EBITDA
6.0x
↓ROE
18.9%
↑Gross Margin
48.2%
↓Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-0.6%
FCF CAGR
—
FCF margin
7.4%
FCF / Net income
1.42x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $292.1M · net income $15.1M · FCF $21.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $292.1M | $292.1M | $286.7M | $297.3M | $297.4M |
| Net Income | $15.1M | $15.1M | $3.7M | $17.4M | $11.0M |
| EBITDA | $32.5M | $32.5M | $20.9M | $30.7M | $25.4M |
| EPS | 0.42 | 0.42 | 0.10 | 0.48 | 0.30 |
| Gross Margin | 48.2% | 48.2% | 46.5% | 47.6% | 45.8% |
| Operating Margin | 6.9% | 6.9% | 2.7% | 6.8% | 4.7% |
| Net Margin | 5.2% | 5.2% | 1.3% | 5.9% | 3.7% |
| Balance Sheet | |||||
| Debt/Equity | — | — | — | — | 0.14 |
| Current Ratio | 1.66 | 1.66 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $21.5M | $21.5M | $4.5M | $16.3M | $-3.2M |
| Returns | |||||
| ROE | 18.9% | 18.9% | 5.0% | 22.1% | 15.0% |
| Valuation | |||||
| P/E | 14.86 | 14.86 | — | — | — |
| EV/EBITDA | 5.98 | 5.98 | — | — | — |
| P/B | 2.80 | 2.80 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 1.9% | 1.9% | -3.6% | -0.0% | — |
| EPS Growth | 320.0% | 320.0% | -79.2% | 60.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
9.6%
EPS terminal req.
$0.55
Spread vs growth
310.4%
5Y implied EPS CAGR
9.8%
EPS terminal req.
$0.67
Spread vs growth
310.2%
10Y implied EPS CAGR
9.9%
EPS terminal req.
$1.08
Spread vs growth
310.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+66.2%
Start / end P/E
37.6x → 14.9x
EPS bridge
0.10 → 0.42
Residual
-193.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.